Works by Cooper, Mark E.

Results: 257
    1
    2
    3
    4
    5
    6
    7
    8

    Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified subgroup analysis of the randomized, placebo‐controlled CARMELINA® trial

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1062, doi. 10.1111/dom.13995
    By:
    • Cooper, Mark E.;
    • Rosenstock, Julio;
    • Kadowaki, Takashi;
    • Seino, Yutaka;
    • Wanner, Christoph;
    • Schnaidt, Sven;
    • Clark, Douglas;
    • Johansen, Odd Erik
    Publication type:
    Article
    9
    10
    11

    Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease.

    Published in:
    Diabetes, Obesity & Metabolism, 2019, v. 21, n. 5, p. 1199, doi. 10.1111/dom.13642
    By:
    • Charytan, David M.;
    • Solomon, Scott D.;
    • Ivanovich, Peter;
    • Remuzzi, Giuseppe;
    • Cooper, Mark E.;
    • McGill, Janet B.;
    • Parving, Hans‐Henrik;
    • Parfrey, Patrick;
    • Singh, Ajay K.;
    • Burdmann, Emmanuel A.;
    • Levey, Andrew S.;
    • Eckardt, Kai‐Uwe;
    • McMurray, John J.V.;
    • Weinrauch, Larry A.;
    • Liu, Jiankang;
    • Claggett, Brian;
    • Lewis, Eldrin F.;
    • Pfeffer, Marc A.
    Publication type:
    Article
    12

    Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA- T2D trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 11, p. 1610, doi. 10.1111/dom.13041
    By:
    • Groop, Per‐Henrik;
    • Cooper, Mark E.;
    • Perkovic, Vlado;
    • Hocher, Berthold;
    • Kanasaki, Keizo;
    • Haneda, Masakazu;
    • Schernthaner, Guntram;
    • Sharma, Kumar;
    • Stanton, Robert C.;
    • Toto, Robert;
    • Cescutti, Jessica;
    • Gordat, Maud;
    • Meinicke, Thomas;
    • Koitka‐Weber, Audrey;
    • Thiemann, Sandra;
    • von Eynatten, Maximilian
    Publication type:
    Article
    13
    14
    15
    16

    Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes.

    Published in:
    Clinical Science, 2016, v. 130, n. 9, p. 711, doi. 10.1042/CS20150838
    By:
    • Coughlan, Melinda T.;
    • Tuong-Vi Nguyen;
    • Penfold, Sally A.;
    • Higgins, Gavin C.;
    • Thallas-Bonke, Vicki;
    • Sih Min Tan;
    • Van Bergen, Nicole J.;
    • Sourris, Karly C.;
    • Harcourt, Brooke E.;
    • Thorburn, David R.;
    • Trounce, Ian A.;
    • Cooper, Mark E.;
    • Forbes, Josephine M.
    Publication type:
    Article
    17
    18
    19
    20
    21

    Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes.

    Published in:
    Clinical Science, 2013, v. 124, n. 3, p. 191, doi. 10.1042/CS20120330
    By:
    • SEDEEK, Mona;
    • GUTSOL, Alex;
    • MONTEZANO, Augusto C.;
    • BURGER, Dylan;
    • NGUYEN DINH CAT, Aurelie;
    • KENNEDY, Chris R. J.;
    • BURNS, Kevin D.;
    • COOPER, Mark E.;
    • JANDELEIT-DAHM, Karin;
    • PAGE, Patrick;
    • SZYNDRALEWIEZ, Cedric;
    • HEITZ, Freddy;
    • HEBERT, Richard L.;
    • TOUYZ, Rhian M.
    Publication type:
    Article
    22
    23
    24

    Targeted deletion of nicotinamide adenine dinucleotide phosphate oxidase 4 from proximal tubules is dispensable for diabetic kidney disease development.

    Published in:
    Nephrology Dialysis Transplantation, 2021, v. 36, n. 6, p. 988, doi. 10.1093/ndt/gfaa376
    By:
    • Thallas-Bonke, Vicki;
    • Tan, Sih Min;
    • Lindblom, Runa S;
    • Snelson, Matthew;
    • Granata, Cesare;
    • Jha, Jay Chandra;
    • Sourris, Karly C;
    • Laskowski, Adrienne;
    • Watson, Anna;
    • Tauc, Michel;
    • Rubera, Isabelle;
    • Zheng, Guoping;
    • Shah, Ajay M;
    • Harris, David C H;
    • Elbatreek, Mahmoud H;
    • Kantharidis, Phillip;
    • Cooper, Mark E;
    • Jandeleit-Dahm, Karin;
    • Coughlan, Melinda T
    Publication type:
    Article
    25
    26
    27
    28

    Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.

    Published in:
    Renal Failure, 2022, v. 44, n. 1, p. 562, doi. 10.1080/0886022X.2022.2056053
    By:
    • Zou, Yutong;
    • Zhao, Lijun;
    • Zhang, Junlin;
    • Wang, Yiting;
    • Wu, Yucheng;
    • Ren, Honghong;
    • Wang, Tingli;
    • Zhang, Rui;
    • Wang, Jiali;
    • Zhao, Yuancheng;
    • Qin, Chunmei;
    • Xu, Huan;
    • Li, Lin;
    • Chai, Zhonglin;
    • Cooper, Mark E.;
    • Tong, Nanwei;
    • Liu, Fang
    Publication type:
    Article
    29
    30
    31

    Pathogenesis of diabetic nephropathy.

    Published in:
    Journal of Diabetes Investigation, 2011, v. 2, n. 4, p. 243, doi. 10.1111/j.2040-1124.2011.00131.x
    By:
    • Cao, Zemin;
    • Cooper, Mark E
    Publication type:
    Article
    32
    33
    34

    Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all‐cause mortality in individuals with type 2 diabetes in the ADVANCE trial.

    Published in:
    Journal of Diabetes, 2020, v. 12, n. 12, p. 929, doi. 10.1111/1753-0407.13083
    By:
    • Kim, Hyunju;
    • Wang, Dan;
    • Chalmers, John;
    • Jun, Min;
    • Zoungas, Sophia;
    • Marre, Michel;
    • Hamet, Pavel;
    • Harrap, Stephen;
    • Mancia, Giuseppe;
    • Poulter, Neil R.;
    • Cooper, Mark E.;
    • Woodward, Mark;
    • Selvin, Elizabeth;
    • Rebholz, Casey M.
    Publication type:
    Article
    35
    36
    37
    38
    39
    40

    Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial.

    Published in:
    2020
    By:
    • Perkovic, Vlado;
    • Toto, Robert;
    • Cooper, Mark E.;
    • Mann, Johannes F.E.;
    • Rosenstock, Julio;
    • McGuire, Darren K.;
    • Kahn, Steven E.;
    • Marx, Nikolaus;
    • Alexander, John H.;
    • Zinman, Bernard;
    • Pfarr, Egon;
    • Schnaidt, Sven;
    • Meinicke, Thomas;
    • von Eynatten, Maximillian;
    • George, Jyothis T.;
    • Johansen, Odd Erik;
    • Wanner, Christoph;
    • CARMELINA investigators
    Publication type:
    journal article
    41
    42
    43
    44

    Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis.

    Published in:
    2019
    By:
    • Pickering, Raelene J.;
    • Tikellis, Christos;
    • Rosado, Carlos J.;
    • Tsorotes, Despina;
    • Dimitropoulos, Alexandra;
    • Smith, Monique;
    • Huet, Olivier;
    • Seeber, Ruth M.;
    • Abhayawardana, Rekhati;
    • Johnstone, Elizabeth K. M.;
    • Golledge, Jonathan;
    • Yutang Wang;
    • Jandeleit-Dahm, Karin A.;
    • Cooper, Mark E.;
    • Pfleger, Kevin D. G.;
    • Thomas, Merlin C.;
    • Johnstone, Elizabeth Km;
    • Wang, Yutang;
    • Pfleger, Kevin Dg
    Publication type:
    journal article
    45

    Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes.

    Published in:
    2017
    By:
    • Kraakman, Michael J.;
    • Man K. S. Lee;
    • Al-Sharea, Annas;
    • Dragoljevic, Dragana;
    • Barrett, Tessa J.;
    • Montenont, Emilie;
    • Basu, Debapriya;
    • Heywood, Sarah;
    • Kammoun, Helene L.;
    • Flynn, Michelle;
    • Whillas, Alexandra;
    • Hanssen, Nordin M. J.;
    • Febbraio, Mark A.;
    • Westein, Erik;
    • Fisher, Edward A.;
    • Chin-Dusting, Jaye;
    • Cooper, Mark E.;
    • Berger, Jeffrey S.;
    • Goldberg, Ira J.;
    • Nagareddy, Prabhakara R.
    Publication type:
    journal article
    46
    47
    48
    49
    50